Stuart McMillan MSP joined MSPs and campaigners to ‘Glow Gold’ in the Scottish Parliament today – and also praised Inverclyde Mum Gill Mowatt in her work to highlight awareness for childhood cancer.
Glow Gold in September for childhood cancer is working as part of childhood cancer awareness month to encourage iconic buildings throughout the UK and the world to light up gold for childhood cancer.
Speaking in the Glow Gold debate in the Scottish Parliament, Stuart McMillan MSP said:
“Childhood cancer remains today the biggest killer of children and young adults after accidental injury. This is an eye-opening statistic, with one in every 285 children and young people being diagnosed with cancer before their 20th birthday.
“For some reason, however, this issue does not seem to get the coverage that some other childhood illnesses receive. In the last 20 years, there have been only three medications licenced for childhood cancer, compared to over 80 medications in the last five years for adult cancers.
Stuart McMillan MSP also highlighted the tireless work of Inverclyde Glow Gold campaigner Gillian Mowatt, whose son was diagnosed with lymphoblastic leukaemia just before his 4th birthday.
“Gillian Mowat is currently running a campaign appealing to the whole of Inverclyde to light up Gold in a visible show of support in September for all childhood cancer patients.
“Gillian has touched the hearts of the people of Inverclyde when she spoke about their ordeal after her son Nathan was diagnosed with the disease.
“I am proud to support Inverclyde mother Gill Mowatt, and the wider Glow Gold campaign. I would like to thank them personally for doing such great work in highlighting the issue of childhood cancer to a wider public.
Mr McMillan emphasized the good work being undertaken between the Scottish Government and Cancer Research UK
“Cancer Research UK is working with the Scottish Government’s Chief Scientist Office and the Teenage Cancer Trust to support research into the barriers to participation in cancer trials amongst teenagers and young adults.
“The Children’s Cancer Trials Team (CCTT), based at the University of Birmingham and funded by Cancer Research UK, is working with investigators around the world to develop new treatments for children with cancer and leukaemia
“Huge progress is being made in the genetic understanding of children’s cancers, as well as in advances in technology and development of personalised medicine.
“We will soon be able to identify the specific genetic make-up of a child’s cancer and match treatments with fewer side effects.”